In this systematic review and meta-analysis of 25 randomised controlled trials involving more than 8,000 participants, we found that people allocated to GLP-1 receptor agonists reported lower binge eating symptoms, loss of control eating, eating disinhibition, and emotional eating compared with those allocated to control groups
This exclusion is significant considering that patients with obesity have a higher risk of developing depression 24
GLP-1 receptor agonist lixisenatide protects against high free fatty acids-induced oxidative stress and inflammatory response
Once you reach a healthy weight-loss pace, which is one to two pounds a week, youll stay at that dose until you achieve your healthy weight goal, even if its less than the maximum 2.4mg
Clinical trials ensure you are receiving the authentic compound under medical supervision, with appropriate monitoring of your health and safety
The Power of Lifestyle: The main strength of this approach is that it is sustainable and completely non-invasive